Concepedia

Author

C. Halldin

Karolinska Institutet

Also Known As

C HALLDIN, C Halldin, C. HALLDIN, C. Halldin, Ch. Halldin, Christer Halldin

59

Publications

1.3K

Citations

12

H-Index

40

Concepts

All Affiliations

Karolinska InstitutetKarolinska University Hospital
CH

About

C. Halldin is an author at Karolinska Institutet specializing in medicine, neurology, and nuclear medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

378

2

Health Sciences

4

4

330

3

Social Sciences

3

3

89

4

Engineering

1

1

55

5

Natural Sciences

1

1

14

C. Halldin

×

12

Publications

1.3K

Citations

12

H-Index

YearCitations

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

Anna Nordström, Lars Farde, Sigrid Nyberg,

American Journal of Psychiatry

1995

337

Suggested Minimal Effective Dose of Risperidone Based on PET-Measured D<sub>2</sub>and 5-HT<sub>2A</sub>Receptor Occupancy in Schizophrenic Patients

Bo Eriksson, Gabriel Oxenstierna, C. Halldin,

American Journal of Psychiatry

1999

246

PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.

Hiroshi Ito, Svante Nyberg, C. Halldin,

PubMed

1998

131

Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.

C. Halldin, Christian Foged, Yuan-Hwa Chou,

PubMed

1998

119

Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography.

Anders Lilja, K Bergström, Per Hartvig,

PubMed

1985

111

New PET radiopharmaceuticals beyond FDG for brain tumor imaging.

Balázs Gulyás, C. Halldin

PubMed

2012

103

European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands.

Klaus Tatsch, S. Asenbaum, P. Bartenstein,

PubMed

2002

65

European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals.

Klaus Tatsch, S. Asenbaum, Peter Bartenstein,

PubMed

2002

61

European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.

P. Bartenstein, S. Asenbaum, A. Catafau,

PubMed

2002

55

Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptors.

Thomas Högberg, Peter Ström, Håkan Hall,

PubMed

1990

14

Page 1